Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Tg Therapeuticscmn (NASDAQ: TGTX)

$10.30 USD -$0.15 (-1.44%)
Last Price $10.3
Net Change $-0.15 (-1.44%)
Bid $10.1
Ask Price $11.3
Open Price $10.5
Previous Close Price $10.45
High Price $10.75
Low Price $10.2
Number of Trades 4,634
Volume 1,121,100
Fifty Two Week High $15.05 (2017-03-16)
Fifty Two Week Low $4.1 (2017-01-24)
Average Daily Volume 1,857,155
Share Outstanding 56,910 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $6.56
Recent Earnings $
Annual EPS $-1.5
Last Quarter EPS $
Market Capitalization $0.59B
Insider Shareholders % 0.19%
Annual Revenue $0B
No. Shares Outstanding 56,910
Inst. Shareholder % 38.12%
Annual Net Income $0B
TTM Net Profit Margin $100.65
1-Year Return 1.78%
3-Year Return 99.61%
5-Year Return 53.27%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 6.56%
Dividends per Share $
Stock Split Ratio 1-56
Beta 1.03
TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various B-cell proliferative disorders including lymphoma, leukemia, and auto-immune diseases. TG Therapeutics, Inc., formerly known as Manhattan Pharmaceuticals, Inc., is based in New York.